Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34998
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPerucca, Emilio-
dc.contributor.authorFrench, Jacqueline A-
dc.contributor.authorAljandeel, Ghaieb-
dc.contributor.authorBalestrini, Simona-
dc.contributor.authorBraga, Patricia-
dc.contributor.authorBurneo, Jorge G-
dc.contributor.authorFelli, Augustina Charway-
dc.contributor.authorCross, J Helen-
dc.contributor.authorGalanopoulou, Aristea S-
dc.contributor.authorJain, Satish-
dc.contributor.authorJiang, Yuwu-
dc.contributor.authorKälviäinen, Reetta-
dc.contributor.authorLim, Shih Hui-
dc.contributor.authorMeador, Kimford J-
dc.contributor.authorMogal, Zarine-
dc.contributor.authorNabbout, Rima-
dc.contributor.authorSofia, Francesca-
dc.contributor.authorSomerville, Ernest-
dc.contributor.authorSperling, Michael R-
dc.contributor.authorTriki, Chahnez-
dc.contributor.authorTrinka, Eugen-
dc.contributor.authorWalker, Matthew C-
dc.contributor.authorWiebe, Samuel-
dc.contributor.authorWilmshurst, Jo M-
dc.contributor.authorWirrell, Elaine-
dc.contributor.authorYacubian, Elza Márcia-
dc.contributor.authorKapur, Jaideep-
dc.date2024-
dc.date.accessioned2024-01-30T23:47:18Z-
dc.date.available2024-01-30T23:47:18Z-
dc.date.issued2024-01-27-
dc.identifier.citationEpilepsia 2024-01-27en_US
dc.identifier.issn1528-1167-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34998-
dc.description.abstractA variety of terms, such as "antiepileptic," "anticonvulsant," and "antiseizure" have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English-language terminology applicable to pharmacological agents currently approved for treating seizure disorders. There was consensus that these medications should be collectively named "antiseizure medications". This term accurately reflects their primarily symptomatic effect against seizures and reduces the possibility of health care practitioners, patients, or caregivers having undue expectations or an incorrect understanding of the real action of these medications. The term "antiseizure" to describe these agents does not exclude the possibility of beneficial effects on the course of the disease and comorbidities that result from the downstream effects of seizures, whenever these beneficial effects can be explained solely by the suppression of seizure activity. It is acknowledged that other treatments, mostly under development, can exert direct favorable actions on the underlying disease or its progression, by having "antiepileptogenic" or "disease-modifying" effects. A more-refined terminology to describe precisely these actions needs to be developed.en_US
dc.language.isoeng-
dc.subjectantiepileptic drugsen_US
dc.subjectantiseizure medicationsen_US
dc.subjectrecommendationsen_US
dc.subjectterminologyen_US
dc.titleWhich terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEpilepsiaen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationNYU Grossman School of Medicine and NYU Langone Health, New York, New York, USA.en_US
dc.identifier.affiliationFaculty of Epileptology, Iraqi Council for Medical Specializations, Medical City, Baghdad, Iraq.en_US
dc.identifier.affiliationNeuroscience Department, Meyer Children's Hospital, Florence, Italy.;University of Florence, Florence, Italy.;Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.en_US
dc.identifier.affiliationInstitute of Neurology, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.en_US
dc.identifier.affiliationDepartment of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.;Department of Epidemiology & Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.;Neuroepidemiology Unit, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.en_US
dc.identifier.affiliation37 Military Hospital, Accra, Ghana.en_US
dc.identifier.affiliationDevelopmental Neurosciences Research and Teaching Department, UCL NIHR BRC Great Ormond Street Institute of Child Health, London, UK.;Department of Neurology, Great Ormond Street Hospital, London, UK.;Young Epilepsy, Lingfield, UK.en_US
dc.identifier.affiliationIsabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, Dominick P Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, New York, USA.en_US
dc.identifier.affiliationIndian Epilepsy Centre, New Delhi, India.en_US
dc.identifier.affiliationDepartment of Pediatrics and Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.;Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.;Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases, Beijing, China.;Key Laboratory for Neuroscience, Ministry of Education/National Health and Family Planning Commission, Peking University, Beijing, China.;Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, China.en_US
dc.identifier.affiliationKuopio Epilepsy Center, Kuopio University Hospital, Kuopio, Finland.;Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.en_US
dc.identifier.affiliationNational Neuroscience Institute, Singapore, Singapore.;Duke-National University of Singapore Medical School, Singapore, Singapore.en_US
dc.identifier.affiliationDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California, USA.en_US
dc.identifier.affiliationNational Epilepsy Center, Jinnah Postgraduate Medical Center, Karachi, Pakistan.en_US
dc.identifier.affiliationReference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker-Enfants Malades Hospital, Paris, France.;Assistance Publique - Hôpitaux de Paris, member of the European Reference Network EpiCARE, Paris, France.;Institut Imagine - INSERM UMR 1163, Paris, France.;Université Paris Cité, Paris, France.en_US
dc.identifier.affiliationInternational Bureau for Epilepsy, Dublin, Ireland.en_US
dc.identifier.affiliationPrince of Wales Hospital, University of New South Wales, Sydney, New South Wales, Australia.en_US
dc.identifier.affiliationDepartment of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.en_US
dc.identifier.affiliationChild Neurology Department, Hedi Chaker University Hospital, LR19ES15, Sfax Medical School, University of Sfax, Sfax, Tunisia.en_US
dc.identifier.affiliationDepartment of Neurology, Neurocritical Care, and Neurorehabilitation, Centre for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria.;Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.en_US
dc.identifier.affiliationDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.en_US
dc.identifier.affiliationDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.en_US
dc.identifier.affiliationDepartment of Pediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.en_US
dc.identifier.affiliationDivisions of Child and Adolescent Neurology and Epilepsy, Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.en_US
dc.identifier.affiliationDepartment of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.en_US
dc.identifier.affiliationDepartment of Neurology, University of Virginia, Charlottesville, Virginia, USA.;UVA Brain Institute, University of Virginia, Charlottesville, Virginia, USA.en_US
dc.identifier.doi10.1111/epi.17877en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-8703-223Xen_US
dc.identifier.orcid0000-0003-2242-8027en_US
dc.identifier.orcid0000-0001-5684-0269en_US
dc.identifier.orcid0000-0001-5639-1969en_US
dc.identifier.orcid0000-0001-7928-375Xen_US
dc.identifier.orcid0000-0002-3644-2826en_US
dc.identifier.orcid0000-0001-6618-2044en_US
dc.identifier.orcid0000-0001-7345-4829en_US
dc.identifier.orcid0000-0002-0472-2903en_US
dc.identifier.orcid0000-0002-0085-6402en_US
dc.identifier.orcid0000-0002-5179-9807en_US
dc.identifier.orcid0000-0003-2935-5131en_US
dc.identifier.orcid0000-0003-1420-0970en_US
dc.identifier.orcid0000-0002-7471-882Xen_US
dc.identifier.orcid0000-0002-4685-2183en_US
dc.identifier.orcid0000-0001-5877-4074en_US
dc.identifier.orcid0000-0002-3172-2669en_US
dc.identifier.orcid0000-0001-8789-1122en_US
dc.identifier.orcid0000-0003-0708-6006en_US
dc.identifier.orcid0000-0003-2918-3819en_US
dc.identifier.orcid0000-0002-5950-2692en_US
dc.identifier.orcid0000-0002-0812-0352en_US
dc.identifier.orcid0000-0002-1061-9099en_US
dc.identifier.orcid0000-0001-7328-1796en_US
dc.identifier.orcid0000-0003-3015-8282en_US
dc.identifier.orcid0000-0001-8367-0189en_US
dc.identifier.orcid0000-0002-8608-1352en_US
dc.identifier.pubmedid38279786-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

26
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.